Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-8-20
pubmed:abstractText
Polymeric immunoglobulins provide first line humoral defense at mucosal surfaces to which they are specifically transported by the polymeric immunoglobulin receptor (pIgR) on mucosal and glandular epithelial cells. Previous studies from our laboratory suggested that amino acids 402-410 of the Calpha3 domain of dimeric IgA (dIgA) represented a potential binding site for the pIgR. Here by binding human secretory component to overlapping decapeptides of Calpha3, we confirm these residues and also uncover an additional site. Furthermore, we show that the Calpha3 motif appears to be sufficient to direct transport of green fluorescent protein through the pIgR-specific cellular transcytosis system. An alternative approach identified phage peptides, selected from a library by the in vitro Madin Darby Canine Kidney transcytosis assay, for pIgR-mediated transport through epithelial cells. Some transcytosis-selected peptides map to the same 402-410 pIgR-binding Calpha3 site. Further in vivo studies document that at least one of these peptides is transported in a rat model measuring hepatic bile transport. In addition to identifying small peptides that are both bound and transported by the pIgR, this study provides evidence that the pIgR-mediated mucosal secretion system may represent a means of targeting small molecule therapeutics and genes to mucosal epithelial cells.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-11602024, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-1372022, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-2111022, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-3518747, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-3524859, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-404358, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-4138538, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-7118912, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-7236608, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-7775483, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-8292260, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-8612228, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-9664402, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-9767462, http://linkedlifedata.com/resource/pubmed/commentcorrection/12186846-9989991
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
19
pubmed:volume
196
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
551-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Targeting mucosal sites by polymeric immunoglobulin receptor-directed peptides.
pubmed:affiliation
Molecular Immunogenetics Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't